Quest Diagnostics (DGX) Tops Q1 EPS by 15c; Raises FY17 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Quest Diagnostics (DGX) PT Raised to $115 at Canaccord Genuity Following Strong 1Q Report; 'Continues to Prove Skeptics Wrong... Q1 was a Blowout'
April 24, 2017 9:35 AM EDTCanaccord Genuity raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following the company's first quarter report.
Analyst Mark Massaro notes the company provided one of its best earnings reports in 4 years, delivering first quarter... More
Quest Diagnostics (DGX) PT Raised to $115 at UBS; 'Improved Growth Profile Continues to Build Confidence'
April 24, 2017 9:14 AM EDTUBS raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $102.00) while maintaining a Buy rating, following a company update post first quarter results.
Analyst A.J. Rice notes management's strong execution of growth opportunities such as hospital deals that could... More
Quest Diagnostics (DGX) PT Raised to $100 at Barclays Following 1Q Report; Best Headline Growth in 2 Years
April 21, 2017 9:15 AM EDTBarclays raised its price target on Quest Diagnostics (NYSE: DGX) to $100.00 (from $98.00) while maintaining a Equalweight rating following the company's first quarter earnings.
Analyst Jack Meehan notes the company provided a sizable beat on volume relative to expectations driven by the best headline... More
Quest Diagnostics (DGX) PT Raised to $115 at Deutsche Bank
April 21, 2017 8:26 AM EDTDeutsche Bank raised its price target on Quest Diagnostics (NYSE: DGX) to $115.00 (from $108.00) while maintaining a Buy rating.
... MoreQuest Diagnostics (DGX) PT Raised to $104.50 at Evercore ISI
April 20, 2017 1:03 PM EDTEvercore ISI raised its price target on Quest Diagnostics (NYSE: DGX) to $104.50 (from $102.00) while maintaining an In Line rating.
Analyst Ross Muken said DGX has become one of the most consistent companies in healthcare. That said, valuation keeps them on the... More
